Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Background/Aims: In this systematic review and meta-analysis, we aimed to clarify the effect of obesity on the occurrence of and mortality from primary liver cancer. Methods: This study was conducted using a systematic literature search of MEDLINE, EMBASE, and the Cochrane Library until November 2018 using the primary keywords “obesity,” “overweight,” “body mass index (BMI),” “body weight,” “liver,” “cancer,” “hepatocellular carcinoma,” “liver cancer,” “risk,” and “mortality.” Studies assessing the relationship between BMI and occurrence of or mortality from primary liver cancer in prospective cohorts and those reporting hazard ratios (HRs) or data that allow HR estimation were included. Results: A total of 28 prospective cohort studies with 8,135,906 subjects were included in the final analysis. These included 22 studies with 6,059,561 subjects for cancer occurrence and seven studies with 2,077,425 subjects for cancerrelated mortality. In the meta-analysis, an increase in BMI was associated with the occurrence of primary liver cancer (HR, 1.69; 95% confidence interval, 1.50–1.90, I2=56%). A BMI-dependent increase in the risk of occurrence of primary liver cancer was reported. HRs were 1.36 (95% CI, 1.02–1.81), 1.77 (95% CI, 1.56–2.01), and 3.08 (95% CI, 1.21–7.86) for BMI >25 kg/m2, >30 kg/m2, and >35 kg/m2, respectively. Furthermore, increased BMI resulted in enhanced liver cancer-related mortality (HR, 1.61; 95% CI, 1.14–2.27, I2=80%). Conclusions: High BMI increases liver cancer mortality and occurrence of primary liver cancer. Obesity is an independent risk factor for the occurrence of and mortality from primary liver cancer.
Abstract
Background/Aims: In this systematic review and meta-analysis, we aimed to clarify the effect of obesity on the occurrence of and mortality from primary liver cancer. Methods: This study was conducted using a systematic literature search of MEDLINE, EMBASE, and the Cochrane Library until November 2018 using the primary keywords “obesity,” “overweight,” “body mass index (BMI),” “body weight,” “liver,” “cancer,” “hepatocellular carcinoma,” “liver cancer,” “risk,” and “mortality.” Studies assessing the relationship between BMI and occurrence of or mortality from primary liver cancer in prospective cohorts and those reporting hazard ratios (HRs) or data that allow HR estimation were included. Results: A total of 28 prospective cohort studies with 8,135,906 subjects were included in the final analysis. These included 22 studies with 6,059,561 subjects for cancer occurrence and seven studies with 2,077,425 subjects for cancerrelated mortality. In the meta-analysis, an increase in BMI was associated with the occurrence of primary liver cancer (HR, 1.69; 95% confidence interval, 1.50–1.90, I2=56%). A BMI-dependent increase in the risk of occurrence of primary liver cancer was reported. HRs were 1.36 (95% CI, 1.02–1.81), 1.77 (95% CI, 1.56–2.01), and 3.08 (95% CI, 1.21–7.86) for BMI >25 kg/m2, >30 kg/m2, and >35 kg/m2, respectively. Furthermore, increased BMI resulted in enhanced liver cancer-related mortality (HR, 1.61; 95% CI, 1.14–2.27, I2=80%). Conclusions: High BMI increases liver cancer mortality and occurrence of primary liver cancer. Obesity is an independent risk factor for the occurrence of and mortality from primary liver cancer.
참고문헌 (59)
- Hruby A, "The epidemiology of obesity: a big picture", Pharmacoeconomics, 33, pp.673~689 (2015)
- Pi-Sunyer X, "The medical risks of obesity", Postgrad Med, 121, pp.21~33 (2009)
- Renehan AG, "Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies", Lancet, 371, pp.569~578 (2008)
- Goodwin PJ, "Impact of the obesity epidemic on cancer", Annu Rev Med, 66, pp.281~296 (2015)
- Parekh N, "Obesity in cancer survival", Annu Rev Nutr, 32, pp.311~342 (2012)
- Wong MC, "International incidence and mortality trends of liver cancer: a global profile", Sci Rep, 7, pp.45846~ (2017)
- Llovet JM, "Hepatocellular carcinoma", Nat Rev Dis Primers, 2, pp.16018~ (2016)
- Ratziu V, "Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis", Hepatology, 35, pp.1485~1493 (2002)
- Ohki T, "Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients", Clin Gastroenterol Hepatol, 6, pp.459~464 (2008)
- Chen CL, "Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B", C infection: a follow-up study in Taiwan, 2008, pp.135, 111~121
- Chen Y, "Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies", Eur J Cancer, 48, pp.2137~2145 (2012)
- Rui R, "Excess body mass index and risk of liver cancer: a nonlinear dose-response metaanalysis of prospective studies", PLoS One, 7, pp.e44522~ (2012)
- Wang Y, "Body mass index and risk of primary liver cancer: a meta-analysis of prospective studies", Oncologist, 17, pp.1461~1468 (2012)
- Stang A, "Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in metaanalyses", Eur J Epidemiol, 25, pp.603~605 (2010)
- Castillo JJ, "Increased incidence of non-Hodgkin lymphoma, leukemia, and myeloma in patients with diabetes mellitus type 2: a meta-analysis of observational studies", Blood, 119, pp.4845~4850 (2012)
- Singh S, "Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis", Gastroenterology, 144, pp.323~332 (2013)
- Park CH, "The association between the use of proton pump inhibitors and the risk of hypomagnesemia:a systematic review and meta-analysis", PLoS One, 9, pp.e112558~ (2014)
- DerSimonian R, "Meta-analysis in clinical trials", Control Clin Trials, 7, pp.177~188 (1986)
- Higgins JP, "Measuring inconsistency in meta-analyses", BMJ, 327, pp.557~560 (2003)
- Egger M, "Bias in metaanalysis detected by a simple, graphical test", BMJ, 315, pp.629~634 (1997)
- Easterbrook PJ, "Publication bias in clinical research", Lancet, 337, pp.867~872 (1991)
- "Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0"[URL]
- Liberati A, "The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration", J Clin Epidemiol, 62, pp.e1~e34 (2009)
- Calle EE, "Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults", N Engl J Med, 348, pp.1625~1638 (2003)
- Batty GD, "Obesity and overweight in relation to organ-specific cancer mortality in London (UK): findings from the original Whitehall study", Int J Obes (Lond), 29, pp.1267~1274 (2005)
- Kuriyama S, "Obesity and risk of cancer in Japan", Int J Cancer, 113, pp.148~157 (2005)
- Rapp K, "Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria", Br J Cancer, 93, pp.1062~1067 (2005)
- N’Kontchou G, "Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis", Clin Gastroenterol Hepatol, 4, pp.1062~1068 (2006)
- Jee SH, "Body mass index and cancer risk in Korean men and women", Int J Cancer, 123, pp.1892~1896 (2008)
- Joshi S, "Socio-economic status and the risk of liver cancer mortality: a prospective study in Korean men", Public Health, 122, pp.1144~1151 (2008)
- Inoue M, "Metabolic factors and subsequent risk of hepatocellular carcinoma by hepatitis virus infection status: a large-scale populationbased cohort study of Japanese men and women (JPHC Study Cohort II)", Cancer Causes Control, 20, pp.741~750 (2009)
- Wang CS, "The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses", Cancer Epidemiol Biomarkers Prev, 18, pp.2054~2060 (2009)
- Hart CL, "Obesity, overweight and liver disease in the Midspan prospective cohort studies", Int J Obes (Lond), 34, pp.1051~1059 (2010)
- Chao LT, "Insulin, glucose and hepatocellular carcinoma risk in male hepatitis B carriers: results from 17-year follow-up of a population-based cohort", Carcinogenesis, 32, pp.876~881 (2011)
- Hung CH, "Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon-based antiviral therapy", Int J Cancer, 128, pp.2344~2352 (2011)
- Borena W, "Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults", Int J Cancer, 131, pp.193~200 (2012)
- Chen CT, "Diabetes mellitus, metabolic syndrome and obesity are not significant risk factors for hepatocellular carcinoma in an HBV- and HCV-endemic area of Southern Taiwan", Kaohsiung J Med Sci, 29, pp.451~459 (2013)
- Li Y, "Body mass index and weight change during adulthood are associated with increased mortality from liver cancer: the JACC Study", J Epidemiol, 23, pp.219~226 (2013)
- Loomba R, "Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study", Am J Epidemiol, 177, pp.333~342 (2013)
- Song X, "Body mass index and cancer incidence: the FINRISK study", Eur J Epidemiol, 29, pp.477~487 (2014)
- Meyer J, "Swiss National Cohort Study Group. Impact of smoking and excess body weight on overall and site-specific cancer mortality risk", Cancer Epidemiol Biomarkers Prev, 24, pp.1516~1522 (2015)
- Campbell PT, "Body mass index, waist circumference, diabetes, and risk of liver cancer for U.S. adults", Cancer Res, 76, pp.6076~6083 (2016)
- Liu Y, "Prospective cohort study of general and central obesity, weight change trajectory and risk of major cancers among Chinese women", Int J Cancer, 139, pp.1461~1470 (2016)
- Setiawan VW, "Sex and ethnic differences in the association of obesity with risk of hepatocellular carcinoma", Clin Gastroenterol Hepatol, 14, pp.309~316 (2016)
- McMahon BJ, "Infection with hepatitis C virus genotype 3 is an independent risk factor for end-stage liver disease, hepatocellular carcinoma, and liver-related death", Clin Gastroenterol Hepatol, 15, pp.431~437.e2 (2017)
- Nderitu P, "The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: a study in the Swedish AMORIS cohort", Int J Cancer, 141, pp.1148~1160 (2017)
- Yang B, "Adiposity across the adult life course and incidence of primary liver cancer: the NIH-AARP cohort", Int J Cancer, 141, pp.271~278 (2017)
- Brichler S, "Non-virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: results of ANRS CO12 CirVir cohort", J Viral Hepat, 26, pp.384~396 (2019)
- Hagström H, "High BMI in late adolescence predicts future severe liver disease and hepatocellular carcinoma:a national, population-based cohort study in 1.2 million men", Gut, 67, pp.1536~1542 (2018)
- Jeong SH, "Body mass index and gastrointestinal cancer mortality in Korean adults: a prospective cohort study", J Gastroenterol Hepatol, 33, pp.1582~1589 (2018)
- Yi SW, "factors for hepatocellular carcinoma by age, sex, and liver disorder status: a prospective cohort study in Korea", Cancer, 124, pp.2748~2757 (2018)
- World Health Organization (WHO), "Obesity: Situation and trends -Global Health Observatory (GHO) data" (2016), WHO
- Park EJ, "Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression", Cell, 140, pp.197~208 (2010)
- Larsson SC, "Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies", Br J Cancer, 97, pp.1005~1008 (2007)
- Pollak M, "Insulin and insulin-like growth factor signalling in neoplasia", Nat Rev Cancer, 8, pp.915~928 (2008)
- Yoshimoto S, "Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome", Nature, 499, pp.97~101 (2013)
- McGlynn KA, "Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability", Clin Liver Dis, 19, pp.223~238 (2015)
- WHO Expert Consultation, "Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies", Lancet, 363, pp.157~163 (2004)
- Yi SW, "Impact of alcohol consumption and body mass index on mortality from nonneoplastic liver diseases, upper aerodigestive tract cancers, and alcohol use disorders in Korean older middle-aged men: prospective cohort study", Medicine (Baltimore), 95, pp.e4876~ (2016)